๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Biochemical markers of trisomy 21 and the pathophysiology of Down's syndrome pregnancies

โœ Scribed by Deborah Newby; David A. Aitken; Jennifer A. Crossley; Alan G. Howatson; James N. Macri; J. Michael Connor


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
204 KB
Volume
17
Category
Article
ISSN
0197-3851

No coin nor oath required. For personal study only.

โœฆ Synopsis


Using biochemical and immunocytochemical methods, we have investigated endogenous levels of various markers in tissues obtained from 67 Down's syndrome pregnancies after therapeutic abortion in the second trimester and in corresponding tissues from unaffected abortuses. Alpha-fetoprotein (AFP), intact and free beta human chorionic gonadotrophin (hCG), pregnancy-specific beta-1 glycoprotein (SP-1), placental alkaline phosphatase (PALP), pregnancy-associated plasma protein A (PAPP-A), and gamma glutamyl transferase (GGT) were investigated in placental tissue; AFP and GGT in fetal liver; and GGT in fetal intestine. The results indicate that maternal serum levels of placental products reflect those found in the placenta: intact hCG, free beta hCG, and SP-1 levels were elevated in Down's syndrome pregnancies, while PAPP-A and PALP levels were little changed. This suggests that membrane passage of these markers is not affected but there is altered synthesis of hCG and SP-1. AFP levels were strikingly elevated in placental homogenates and unchanged in liver homogenates from Down's syndrome pregnancies, while the levels in maternal serum were reduced, pointing to a possible transport defect specific to AFP. GGT levels were high in placenta and liver from Down's syndrome pregnancies but low in fetal intestine.


๐Ÿ“œ SIMILAR VOLUMES


BIOCHEMICAL MARKERS OF TRISOMY 21 IN AMN
โœ K. SPENCER; F. MULLER; D. A. AITKEN ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 638 KB

In a study of amniotic fluid from 91 Down's syndrome cases and 240 controls, we have shown that the median values of four biochemical markers (AFP, total hCG, free beta hCG, and unconjugated oestriol) in the amniotic fluid of pregnancies affected by Down's syndrome on the whole reflect those observe

The human trisomy 21 brain: Insights fro
โœ Holtzman, David M. ;Epstein, Charles J. ;Mobley, William C. ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 887 KB

One of the most common genetic disorders, Down syndrome has involved physicians and scientists from many disciplines in the attempt t o understand the varied and sometimes specific phenotypes resulting from the presence of extra genetic material on human chromosome 21. Among the nervous system pheno

Second-trimester prenatal screening for
โœ Kevin Spencer ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 60 KB ๐Ÿ‘ 3 views

In a group of 26 524 control pregnancies and a group of 3728 pregnancies affected by one or more of the pregnancy complications of low birthweight, intra-uterine growth restriction (IUGR), preterm delivery and stillbirth, I have compared the relative risk of occurrence of these complications in preg

Is maternal serum total hCG a marker of
โœ Kevin Spencer; Esther Berry; Jennifer A. Crossley; David A. Aitken; Kypros H. Ni ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 89 KB ๐Ÿ‘ 3 views

In a study of 130 ยฎrst trimester cases of trisomy 21 and 959 controls we have shown that the median MoM for alpha-fetoprotein (AFP) is lower (0.82) and that for total human chorionic gonadotrophin (hCG) is higher (1.31) than in the control group. For AFP 15.3% of cases were below the 5th centile and